Status:
UNKNOWN
Histologic Evolution of Patients With Liver Transplantation
Lead Sponsor:
Hospital Vall d'Hebron
Collaborating Sponsors:
Spanish Society of Pediatric Gastroenterology, Hepatology and Nutrition
Conditions:
Liver Transplant Failure and Rejection
Children, Only
Eligibility:
All Genders
2-18 years
Brief Summary
Certain pediatric liver transplant patients with immunosuppression levels in the therapeutic range and normal liver function tests present histological alterations (inflammation or fibrosis) in protoc...
Detailed Description
Given the increase in survival of both the graft and the transplanted patient, new questions arise regarding long-term follow-up. In general, transplant patients undergo follow-up visits that include ...
Eligibility Criteria
Inclusion
- Patients between 2-18 years old who have received a liver transplant at least two years ago
- Follow-up in pediatric hepatology and liver transplant outpatient clinics at the Vall d'Hebron Hospital
- Performing tests, ultrasound, elastography and biopsy during the last year as part of the follow-up protocol of our center
- Patients who have signed the informed consent for inclusion in the study and the corresponding assents.
Exclusion
- Patients who do not meet all the inclusion criteria of the protocol.
- Patients who are transplant recipients of multiple solid organs.
Key Trial Info
Start Date :
March 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06103097
Start Date
March 15 2019
End Date
December 31 2024
Last Update
October 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari Vall d'Hebron
Barcelona, Catalonia, Spain, 08035